Stock & Company Details
Ascendis Pharma A/S Ordinary Share $ASND
Price:
N/A
N/A
N/A
$15B
52 Week High:
N/A
10 Day Average Volume:
N/A
29.33
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
N/A
ASND technical indicators
Latest Ascendis Pharma A/S Ordinary Share (ASND) indicator readings as of 2026-10-08.
ASND's 14-day RSI is 35.2, in neutral territory. ADX reads 39.0, indicating a trending market. MACD (12, 26, 9) is -7.23, below the zero line.
ASND backtested strategy results
How 4 rule-based strategies performed on Ascendis Pharma A/S Ordinary Share (ASND) over recent history, last backtested 2026-10-08. Select a strategy to plot its trades on the chart above. Past performance does not predict future results.
| Strategy | Equity curve | Return | Win rate | Trades | Max drawdown |
|---|---|---|---|---|---|
| Oversold Bounce Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | +0.0% | 0% | 0 | 0.0% | |
| Momentum Crossover Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | +9.2% | 100% | 1 | -0.3% | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | -0.4% | 0% | 1 | -0.4% | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | +0.0% | 0% | 0 | 0.0% |
Overview
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
Finance Bot
Ask your questions
Start by typing a question below.
